Cargando…

Multi-Omics Data Analyses Identify B7-H3 as a Novel Prognostic Biomarker and Predict Response to Immune Checkpoint Blockade in Head and Neck Squamous Cell Carcinoma

B7 homolog 3 (B7-H3) is a recently found superfamily B7 molecule and therefore has significant involvement in immunological regulation. However, the relationships of B7-H3 expression with the tumor microenvironment (TME), response to immunotherapy, and prognosis in head and neck squamous cell carcin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Wanzun, Xu, Yanyan, Gao, Jing, Zhang, Haojiong, Sun, Yun, Qiu, Xianxin, Huang, Qingting, Kong, Lin, Lu, Jiade J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524082/ https://www.ncbi.nlm.nih.gov/pubmed/34675936 http://dx.doi.org/10.3389/fimmu.2021.757047

Ejemplares similares

Preliminary clinical outcomes of head and neck squamous cell carcinoma treated with particle beam radiation therapy
por: Huang, Qingting, et al.
Publicado: (2023)

Identification of molecular subtypes based on inflammatory response in lower-grade glioma
por: Lin, Wanzun, et al.
Publicado: (2022)

VMP1, a novel prognostic biomarker, contributes to glioma development by regulating autophagy
por: Lin, Wanzun, et al.
Publicado: (2021)

Tumor-intrinsic YTHDF1 drives immune evasion and resistance to immune checkpoint inhibitors via promoting MHC-I degradation
por: Lin, Wanzun, et al.
Publicado: (2023)

Association of IDH mutation and 1p19q co-deletion with tumor immune microenvironment in lower-grade glioma
por: Lin, Wanzun, et al.
Publicado: (2021)

Comparison of the efficacy and toxicity of postoperative proton versus carbon ion radiotherapy for head and neck cancers
por: Huang, Qingting, et al.
Publicado: (2022)

Particle beam radiation therapy for head and neck rhabdomyosarcoma in adults
por: Yang, Jing, et al.
Publicado: (2022)

Combining Radiation and Immune Checkpoint Blockade in the Treatment of Head and Neck Squamous Cell Carcinoma
por: Manukian, Gregor, et al.
Publicado: (2019)

Multi-Omics Analyses to Identify FCGBP as a Potential Predictor in Head and Neck Squamous Cell Carcinoma
por: Lin, Yu-Hsuan, et al.
Publicado: (2022)

Clinical-genomic determinants of immune checkpoint blockade response in head and neck squamous cell carcinoma
por: Valero, Cristina, et al.
Publicado: (2023)

Intensity‐Modulated Proton and Carbon‐Ion Radiation Therapy in the Management of Head and Neck Sarcomas
por: Yang, Jing, et al.
Publicado: (2019)

Particle Beam Radiation Therapy for Adenoid Cystic Carcinoma of the Nasal Cavity and Paranasal Sinuses
por: Hu, Weixu, et al.
Publicado: (2020)

Particle beam radiation therapy for sinonasal malignancies: Single institutional experience at the Shanghai Proton and Heavy Ion Center
por: Hu, Weixu, et al.
Publicado: (2020)

Intensity-modulated proton and carbon-ion radiation therapy in the management of major salivary gland carcinomas
por: Huang, Qingting, et al.
Publicado: (2022)

Carbon-ion radiotherapy in the treatment of radiation-induced second primary malignancies
por: Yang, Jing, et al.
Publicado: (2022)

Carbon-ion radiotherapy boost with standard dose proton radiation for incomplete-resected high-grade glioma: a phase 1 study
por: Qiu, Xianxin, et al.
Publicado: (2022)

The role of carbon-ion radiotherapy in the treatment of adenoid cystic carcinoma of the nasopharynx
por: Hu, Jiyi, et al.
Publicado: (2022)

In vitro evaluation of photon and carbon ion radiotherapy in combination with cisplatin in head and neck squamous cell carcinoma cell lines
por: Fang, Xumeng, et al.
Publicado: (2023)

Identification of pyroptosis‐related gene prognostic signature in head and neck squamous cell carcinoma
por: Li, Zhanzhan, et al.
Publicado: (2022)

Identification of immune‐related lncRNA panel for predicting immune checkpoint blockade and prognosis in head and neck squamous cell carcinoma
por: Li, Qun, et al.
Publicado: (2022)

Integrative Tumor and Immune Cell Multi-omic Analyses Predict Response to Immune Checkpoint Blockade in Melanoma
por: Anagnostou, Valsamo, et al.
Publicado: (2020)

Immune Checkpoints Pathways in Head and Neck Squamous Cell Carcinoma
por: Veigas, Florencia, et al.
Publicado: (2021)

Particle Beam Radiation Therapy for Skull Base Sarcomas
por: Yang, Jing, et al.
Publicado: (2020)

Clinical outcomes of carbon‐ion radiotherapy for patients with locoregionally recurrent nasopharyngeal carcinoma
por: Hu, Jiyi, et al.
Publicado: (2020)

Mixed Photon and Carbon-Ion Beam Radiotherapy in the Management of Non-Metastatic Nasopharyngeal Carcinoma
por: Hu, Jiyi, et al.
Publicado: (2021)

Checkpoint blockade-induced CD8+ T cell differentiation in head and neck cancer responders
por: Zhou, Liye, et al.
Publicado: (2022)

Statin drugs enhance responses to immune checkpoint blockade in head and neck cancer models
por: Kansal, Vikash, et al.
Publicado: (2023)

Digital Spatial Profiling Links Beta-2-microglobulin Expression with Immune Checkpoint Blockade Outcomes in Head and Neck Squamous Cell Carcinoma
por: Gavrielatou, Niki, et al.
Publicado: (2023)

Advances in T-cell checkpoint immunotherapy for head and neck squamous cell carcinoma
por: Qi, Xinmeng, et al.
Publicado: (2017)

Immune checkpoint pathways in immunotherapy for head and neck squamous cell carcinoma
por: Mei, Zi, et al.
Publicado: (2020)

A cross-sectional analysis of registered clinical trials on the use of particle beam radiation therapy in head and neck cancers
por: Zhang, Wenna, et al.
Publicado: (2022)

Correction: Statin drugs enhance responses to immune checkpoint blockade in head and neck cancer models
Publicado: (2023)

Bayesian Networks to Support Decision-Making for Immune-Checkpoint Blockade in Recurrent/Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC)
por: Huehn, Marius, et al.
Publicado: (2021)

Genomic and Molecular Profiling of Human Papillomavirus Associated Head and Neck Squamous Cell Carcinoma Treated with Immune Checkpoint Blockade Compared to Survival Outcomes
por: Shaikh, Hira, et al.
Publicado: (2021)

Development and Validation of a Robust Immune Prognostic Signature for Head and Neck Squamous Cell Carcinoma
por: Qiu, Yu, et al.
Publicado: (2020)

Identification of an individualized therapy prognostic signature for head and neck squamous cell carcinoma
por: Lin, Cheng, et al.
Publicado: (2023)

Prediction of Radiosensitivity in Head and Neck Squamous Cell Carcinoma Based on Multiple Omics Data
por: Liu, Jie, et al.
Publicado: (2020)

Interleukin-1 blockade overcomes erlotinib resistance in head and neck squamous cell carcinoma
por: Stanam, Aditya, et al.
Publicado: (2016)

[(18)F]FDG-PET accurately identifies pathological response early upon neoadjuvant immune checkpoint blockade in head and neck squamous cell carcinoma
por: Vos, Joris L., et al.
Publicado: (2021)

Overcoming Resistance to Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinomas
por: dos Santos, Lucas V., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i6t9703hckoi93fdtdcm9v9sk7